A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial
Titel:
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial
Auteur:
Guimarães, Helio P. de Barros e Silva, Pedro G.M. Liporace, Idelzuita L. Sampaio, Roney O. Tarasoutchi, Flávio Paixão, Milena Hoffmann-Filho, Conrado R. Patriota, Rodrigo Leiria, Tiago L.L. Lamprea, Diana Precoma, Dalton B. Atik, Fernando A. Silveira, Fabio S. Farias, Fabio R. Barreto, Diogo O. Almeida, Adail P. Zilli, Alexandre C. de Souza Neto, João D. Cavalcante, Margaret A. Figueira, Fernando A.M.S. Junior, Roque A. Moisés, Valdir A. Mesas, Cezar E. Ardito, Roberto V. Kalil, Paulo S.A. Paiva, Maria S.M.O. Maldonado, Jaime G.A. de Lima, Carlos E.B. D'Oliveira Vieira, Ricardo Laranjeira, Ligia Kojima, Flávia Damiani, Lucas Nakagawa, Renato H. dos Santos, Juliana R.Y. Sampaio, Bruna S. Campos, Viviane B. Saraiva, Jose F.K. Fonseca, Francisco H. Pinto, Ibraim M. Magalhães, Carlos C. Ferreira, Joao F.M. Lopes, Renato D. Pavanello, Ricardo Cavalcanti, Alexandre B. Berwanger, Otavio